Skip to main content

Table 3 Genotype distributions of rs7779972 between VKH case and control groups

From: Association of ZC3HAV1 single nucleotide polymorphisms with the susceptibility of Vogt-Koyanagi-Harada Disease

Genotype

VKH

Controls

P

OR (95% CI)

n (%)

n (%)

First

    

 AA

47(12.6)

25(6.6)

0.005

2.059(1.239–3.422)

 AG

168(45.2)

160(42.0)

0.381

1.138(0.853–1.518)

 GG

157(42.2)

196(51.4)

0.011

0.689(0.517–0.919)

Second

    

 AA

44(12.1)

45(8.7)

0.110

1.429(0.921–2.216)

 AG

170(46.6)

222(41.2)

0.320

1.147(0.876–1.502)

 GG

151(41.4)

247(48.1)

0.050

0.763(0.582-1.000)

Combined

    

 AA

91(12.3)

70(7.8)

2.28 × 10− 3

1.660(1.196–2.305)

 AG

338(45.9)

382(42.7)

0.198

1.138(0.935–1.384)

 GG

308(41.8)

443(49.5)

1.88 × 10 − 3

0.733(0.602–0.892)

  1. VKH: Vogt-Koyanagi-Harada Disease; OR: Odd ratios; 95% CI :95% confidence interval
  2. P: P-value which was calculated by χ2 test lower than 2.08 × 10− 3 (0.05/24) has statistical significance, and indicated by boldface